Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Pharmacies in Scotland supplied over 9,000 take-home naloxone kits in 2020/21

Community pharmacies in Scotland dispensed or issued more than 9,000 take-home naloxone kits in 2020/21, a report has revealed.

Of the 22,366 kits issued in 2020/21 as part of the National Naloxone Programme, 13,933 were handed to patients from community outlets including pharmacies, according to a report by Public Health Scotland (PHS), which was published yesterday (May 3).

Community pharmacies supplied 1,999 kits either upon patients’ requests or along with a patient’s prescribed medication and a further 7,045 kits were dispensed via a named community prescription, a PHS spokesperson confirmed to C+D today (May 4).

 

Read more: Plans for pharmacists to supply take-home naloxone garner strong support

 

The number of kits dispensed via a named community prescription saw a sharp increase on the previous year, when 809 such kits were dispensed via this route.

During the COVID-19 pandemic, the supply of take-home naloxone kits was extended to non-drug treatment services, which allowed community pharmacies to give out the kits as non-prescribed medication, according to the report.

 

Variation in service provision

 

The report found that in 2020/21, the supply of take-home naloxone kits via community pharmacies increased in some NHS boards that “had rarely utilised prescribing as a means of naloxone provision”.

Community Pharmacy Scotland director Matt Barclay told C+D today that provision of naloxone services via the pharmacy network varies at a local level, “but we know that many health boards and pharmacies do provide this service in their areas and the evidence through PHS suggests this”.

 

Read more: Community pharmacy: the forgotten frontline against drug-related deaths

 

“Community pharmacy provision of naloxone is an obvious route given the contact community pharmacy teams can have with patients on a regular basis.

“We are keen to explore what a national service involving naloxone supply could look like through community pharmacy as the national Drugs Death Taskforce continues to look at ways of tackling drugs deaths,” Mr Barclay added.

The public seems to be in favour of allowing the supply of take-home naloxone via pharmacies without a prescription, according to the responses shared with the Department of Health and Social Care – which consulted on proposing to widen the access to the drug that can reverse the effects of opioid overdoses last year.

Related Content

Topics

         
Pharmacist Manager
Oxford
£ Competitive

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD136092

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel